Diabetes mellitus in alcohol-associated liver disease: Prevalence and outcomes
DM is a frequent comorbidity in persons with ALD and is associated with a higher risk of liver-related mortality. Patients' diabetic status should be an important consideration for clinicians treating people with ALD.
Authors
- Michael Allison (ORCID: https://orcid.org/0000-0003-3677-3294)
- Ian Rowe (ORCID: https://orcid.org/0000-0003-1288-0749)
- Keval Naik
- Ben A. Ward (ORCID: https://orcid.org/0000-0003-1290-8270)
- Mark Theodoreson
- Ewan H. Forrest (ORCID: https://orcid.org/0000-0002-7293-2574)
- Richard A. Parker (ORCID: https://orcid.org/0000-0003-4888-8670)
- Steven Masson (ORCID: https://orcid.org/0000-0003-1041-9844)
- Neil Rajoriya (ORCID: https://orcid.org/0000-0003-3892-2206)
- Hannes Hagström (ORCID: https://orcid.org/0000-0002-8474-1759)
- Mayur Brahmania (ORCID: https://orcid.org/0000-0002-4671-1479)
- Anne McCune
- Guruprasad Padur Aithal (ORCID: https://orcid.org/0000-0003-3924-4830)
Institutions
- University of Leeds (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Karolinska University Hospital (SE)
- University of Calgary (CA)
- Glasgow Royal Infirmary (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- St James's University Hospital (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Karolinska Institutet (SE)
- Bristol Hospital (US)
- NIHR Newcastle Biomedical Research Centre (GB)
- Nottingham Biomedical Research Centre (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1097/hc9.0000000000000734
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00